NY-ESO-1 expression in sarcomas: A diagnostic marker and immunotherapy target (Q36456502)

14 August 2017

NY-ESO-1 expression in sarcomas: A diagnostic marker and immunotherapy target (English)

1 reference

14 August 2017

1 reference

Avi Z Rosenberg

2

0 references

author name string

Jin-Ping Lai

series ordinal

1

1 reference

PMCID

3518519

14 August 2017

Markku M Miettinen

series ordinal

3

1 reference

PMCID

3518519

14 August 2017

Chyi-Chia R Lee

series ordinal

4

1 reference

14 August 2017

1 November 2012

1 reference

14 August 2017

1 reference

14 August 2017

1

1 reference

14 August 2017

1409-1410

1 reference

14 August 2017

8

1 reference

NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518519

Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518519

Myxoid/round cell and pleomorphic liposarcomas: prognostic factors and survival in a series of patients treated at a single institution

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518519

Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518519

Cancer immunotherapy in clinical oncology

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518519

Identification of CD4+ T cell epitopes from NY-ESO-1 presented by HLA-DR molecules

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518519

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3518519

NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis.

30 September 2017

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23243610

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23243610

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4161/ONCI.21059

1 reference

14 August 2017

1 reference

14 August 2017

1 reference

PMCID

3518519